Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT04457050
Eligibility Criteria:
Inclusion Criteria:
* Hepatitis C treatment-naïve;
* Non-diabetic patients.
Exclusion Criteria:
* Seropositivity for hepatitis B virus infection;
* Diabetes mellitus;
* Bbody mass index ≥ 30 Kg/M\*2;
* History of alcohol consumption;
* Endocrinopathies that may affect the glycemic homeostasis;
* Other known causes of chronic liver disease; Hepatic decompensation \[defined as history of gastrointestinal bleeding (melena and /or hematemesis), jaundice, coagulopathy, hepatic encephalopathy, and/or ascites\]; bleeding diathesis;
* Connective tissue diseases;
* Autoimmune diseases;
* Cardiac, respiratory or renal disease.
* Patient receiving immuno-modulatory therapy or drugs that affect the blood glucose levels such as steroids or beta-blockers.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04457050
Study Brief:
Protocol Section:
NCT04457050